Skip to main content
. 2022 Dec 30;8(3):531–543. doi: 10.1016/j.ekir.2022.12.020

Figure 3.

Figure 3

Risk factors for the development of BKPyVAN. BKPyVAN, BK polyomavirus-associated nephropathy; CNI, x; HLA-DR, human leucocyte antigen.